Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biopha.2017.12.045PMID 29272787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4

  2017cited by this paper
• ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways

  2017cited by this paper
• Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3

  2016cited by this paper
• BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs

  2015cited by this paper
• The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer

  2015cited by this paper
• ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.

  2015cited by this paper
• ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression

  2015cited by this paper
• MicroRNA-618 modulates cell growth via targeting PI3K/Akt pathway in human thyroid carcinomas.

  2015cited by this paper
• ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer

  2015cited by this paper
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.

  2015cited by this paper
• Pax-8–PPAR-γ fusion protein in thyroid carcinoma

  2014cited by this paper
• Serum response factor induces epithelial to mesenchymal transition with resistance to sorafenib in hepatocellular carcinoma.

  2014cited by this paper
• High MET Receptor Expression But Not Gene Amplification in ALK 2p23 Rearrangement Positive Non–Small-Cell Lung Cancer

  2014cited by this paper
• Keep‐ING balance: Tumor suppression by epigenetic regulation

  2014cited by this paper
• HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.

  2013cited by this paper
• HGF/c-Met Overexpressions, but not Met Mutation, Correlates with Progression of Non-small Cell Lung Cancer

  2012cited by this paper
• Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

  2012cited by this paper
• Cyclooxygenase‐2 and Akt mediate multiple growth‐factor‐induced epithelial‐mesenchymal transition in human hepatocellular carcinoma

  2012cited by this paper
• Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis.

  2012cited by this paper
• The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.

  2011cited by this paper
• Significance of Metastatic Lymph Node Ratio on Stimulated Thyroglobulin Levels in Papillary Thyroid Carcinoma after Prophylactic Unilateral Central Neck Dissection

  2011cited by this paper
• The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.

  2011cited by this paper
• Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma

  2010cited by this paper
• Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.

  2010cited by this paper
• Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

  2009cited by this paper
• Reviewing the current classification of inhibitor of growth family proteins

  2009cited by this paper
• The Met tyrosine kinase receptor in development and cancer

  2008cited by this paper
• Targeting the c-Met signaling pathway in cancer.

  2008cited by this paper
• Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.

  2007cited by this paper
• After a decade of study-ING, a PHD for a versatile family of proteins.

  2007cited by this paper
• Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis.

  2006cited by this paper
• ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.

  2006cited by this paper
• Targeting the c-Met Signaling Pathway in Cancer

  2006cited by this paper
• Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo

  2005cited by this paper
• Biological functions of the ING family tumor suppressors

  2004cited by this paper
• Met, metastasis, motility and more

  2003cited by this paper
• Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients

  2002cited by this paper

• ING5: multifaceted roles beyond tumor suppression in cellular physiology and disease

  2025cites this paper
• Combined detection of inflammatory proteins is beneficial for diagnosing the papillary thyroid carcinoma and nodular goiter

  2024cites this paper
• Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors

  2024cites this paper
• Strategies to Investigate Migration and Metastases in Thyroid Cancer

  2024cites this paper
• Investigation of the effects of phthalates on in vitro thyroid models with RNA-Seq and ATAC-Seq

  2023cites this paper
• Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer

  2022cites this paper
• Targeted therapy and drug resistance in thyroid cancer.

  2022cites this paper
• CircSND1/miR-182-5p Axis Promotes Proliferative and Invasive Abilities of Thyroid Cancer via Binding Targeting MET

  2022cites this paper
• Newly identified tumor suppressor functions of ING proteins.

  2022cites this paper
• The roles of ING5 in cancer: A tumor suppressor

  2022cites this paper
• CircBLNK regulates tumor proliferation and apoptosis by miR-578/ING5 axis in non-small cell lung cancer

  2022cites this paper
• IncRNA TYMSOS Promotes Epithelial-Mesenchymal Transition and Metastasis in Thyroid Carcinoma through Regulating MARCKSL1 and Activating the PI3K/Akt Signaling Pathway.

  2022cites this paper
• A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial–Mesenchymal Transition in Prostate Cancer Cells

  2021cites this paper
• Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma

  2021cites this paper
• Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer

  2021cites this paper
• Proteomic and phosphoproteomic analyses identify liver-related signaling in retinal pigment epithelial cells during EMT.

  2021cites this paper
• E-cadherin on epithelial–mesenchymal transition in thyroid cancer

  2021cites this paper
• OTT_A_301127 3119..3131

  2021cites this paper
• Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.

  2020cites this paper
• CUL4B promotes aggressive phenotypes of renal cell carcinoma via upregulating c-Met expression.

  2020cites this paper
• Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis

  2020cites this paper
• Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction.

  2020cites this paper
• miR-27a-3p attenuates induce autophagy-related cell death by suppressing Inhibitor of growth family 5 in cholangiocarcinoma

  2020cites this paper
• Role of PI3K/AKT pathway in cancer: the framework of malignant behavior

  2020cites this paper
• MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5

  2020cites this paper
• Structure-activity relationship study of novel quinazoline-based 1,6-naphthyridinones as MET inhibitors with potent antitumor efficacy.

  2020cites this paper
• MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer.

  2020cites this paper
• Acetylshikonin inhibits the migration and invasion of A375 cells by reversing EMT process via the PI3K/Akt/mTOR pathway

  2019cites this paper
• ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance

  2019cites this paper
• CircRNA circ_0067934 Overexpression Correlates with Poor Prognosis and Promotes Thyroid Carcinoma Progression

  2019cites this paper
• Expression analysis of microRNAs and mRNAs in myofibroblast differentiation of lung resident mesenchymal stem cells.

  2019cites this paper
• Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review

  2019cites this paper
• Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells

  2018influential citation